Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Roth, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, S. H.
Related Collections
Right arrow Osteoarthritis and Cartilage
Right arrow Psychology: Measurement and Management of Pain
Right arrow Education
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 603-606
© 2001 British Society for Rheumatology

Editorials

Arthritis therapy: a better time, a better day

S. H. Roth Aging and Arthritis Program, Graduate Colleges, Arizona State University, Tempe, Arizona, USA

At a time when our arthritis armamentarium has clearly expanded beyond anything we have experienced in our previous medical lifetime, it behoves us to pause and reflect. How different are the new COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) from their predecessors? Does their aggressive marketing distract from a balanced therapeutic approach to pain, suffering and deadly disease? We face a new challenge in our responsibility to respect and utilize unique advances in the international pain community.

We are still trying to sort out a rational approach to combinations of our potent but toxic disease-modifying drugs. How do the incredibly effective biologicals fit into this schema? What changes in timing and choices do these immunomodulating advances, and even an ‘arthritis machine’, portend for our structured attempts to create rational algorithms for our treatment efforts? The new additions are as impressive as they are varied. This editorial is an attempt to sort them . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
S. H. Roth and J. Z. Shainhouse
Efficacy and Safety of a Topical Diclofenac Solution (Pennsaid) in the Treatment of Primary Osteoarthritis of the Knee: A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial
Arch Intern Med, October 11, 2004; 164(18): 2017 - 2023.
[Abstract] [Full Text] [PDF]